Product Information
DONEPEZIL HCL 5 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0440 per EA under NDC 62332009230. Its NADAC has been published 549 times since Mar 30, 2016.
FDA first approved this application on Feb 25, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332009230
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DONEPEZIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201724FDA Approved
2/25/2013
TE Code
AB
On Market Since
1/29/2016
Pharmacological Classes
Price Statistics
The NADAC for DONEPEZIL HCL 5 MG TABLET has been published 549 times since Mar 30, 2016, and over the history we have for it it has declined 39.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0440 per EA |
|---|---|
| All-time high | $0.0722 (Apr 13, 2016) |
| All-time low | $0.0334 (May 22, 2024) |
| 52-week high | $0.0446 |
| 52-week low | $0.0424 |
| Median price | $0.0505 |
| Average price | $0.0509 |
| Largest weekly change | +28.3% (Nov 22, 2023) |
| Weeks tracked | 549 |
| Tracking since | Mar 30, 2016 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Donepezil Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinesterase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DONEPEZIL HCL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DONEPEZIL HCL 5 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0440 per EA (NDC 62332009230), effective Sep 30, 2026.
How has the price of DONEPEZIL HCL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for DONEPEZIL HCL 5 MG TABLET has declined 39.1%. It has been tracked across 549 weekly CMS publications since Mar 30, 2016.
What are the highest and lowest recorded NADAC prices for DONEPEZIL HCL 5 MG TABLET?
Since Mar 30, 2016, the NADAC for DONEPEZIL HCL 5 MG TABLET has ranged from a low of $0.0334 (May 22, 2024) to a high of $0.0722 (Apr 13, 2016), with a median of $0.0505 per EA.
Are there cheaper alternatives to DONEPEZIL HCL 5 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DONEPEZIL HCL 5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DONEPEZIL HCL 5 MG TABLET?
DONEPEZIL HCL 5 MG TABLET (NDC 62332009230) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.